Medpace Holdings (MEDP) Common Equity (2014 - 2026)

Medpace Holdings (MEDP) has reported Common Equity for 13 consecutive years, with $598.3 million the latest figure, recorded in Q1 2026.

• Common Equity for Q1 2026 came in at $598.3 million, up 0.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $598.3 million (up 0.79% YoY), and the FY2025 annual result was $459.1 million, down 44.39% from the prior year.
• Common Equity was $598.3 million for Q1 2026 at Medpace Holdings, up from $459.1 million in the prior quarter.
• Over five years, Common Equity peaked at $881.4 million in Q3 2024 and troughed at $172.4 million in Q2 2025.
• Average Common Equity over 5 years is $508.9 million, with a median of $470.9 million recorded in 2023.
• Year-over-year, Common Equity surged 95.26% in 2024 and plunged 77.43% in 2025.
• Over 5 years, Common Equity stood at $386.4 million in 2022, then soared by 44.66% to $558.9 million in 2023, then soared by 47.7% to $825.5 million in 2024, then plunged by 44.39% to $459.1 million in 2025, then soared by 30.33% to $598.3 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $598.3 million in Q1 2026, $459.1 million in Q4 2025, and $293.6 million in Q3 2025.